Skip to main content
. 2016 Oct 3;4(1):e000294. doi: 10.1136/bmjdrc-2016-000294

FigureĀ 2.

FigureĀ 2

Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and in subjects (E) without cardiovascular diseases (CVD) and (F) with CVD.